(Total Views: 488)
Posted On: 02/10/2020 9:00:49 AM
Post# of 153986
found this so some info is getting out -
https://translate.google.com/translate?hl=en&...rev=search
Quote:
The leronlimab project of CytoDyn, USA
CytoDyn is investigating the CCR5 antagonist leronlimab (PRO 140) as a potential treatment for 2019-nCOV. The drug has been studied as a treatment for HIV in Phase II clinical trials and has received a fast track grant from the US FDA.
https://translate.google.com/translate?hl=en&...rev=search
(1)
(0)
